Comparing Mavyret vs Sofosbuvir / Velpatasvir
| Mavyret (glecaprevir / pibrentasvir) | Sofosbuvir / velpatasvir |
|
|---|
| Mavyret (glecaprevir / pibrentasvir) | Sofosbuvir / velpatasvir |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Mavyret is an antiviral combination agent that is approved to treat all six genotypes (1-6) of hepatitis C virus (HCV) in adults and children aged 12 years of age and older. It is one of the most... View more |
Prescription only
Prescribed for Hepatitis C. Sofosbuvir / velpatasvir may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||||||||||
| More about Mavyret (glecaprevir / pibrentasvir) | More about Sofosbuvir / velpatasvir | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Mavyret has an average rating of 8.3 out of 10 from a total of 428 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 7% reported a negative effect. |
Sofosbuvir / velpatasvir has an average rating of 7.6 out of 10 from a total of 418 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 12% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Mavyret side effects |
|
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Mavyret prices |
View all Sofosbuvir / velpatasvir prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Epclusa | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
13 hours |
27 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 212 drugs are known to interact with Mavyret:
|
A total of 195 drugs are known to interact with Sofosbuvir / velpatasvir:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
August 03, 2017 |
June 28, 2016 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.